全文获取类型
收费全文 | 1553003篇 |
免费 | 332715篇 |
国内免费 | 40715篇 |
专业分类
耳鼻咽喉 | 18964篇 |
儿科学 | 47150篇 |
妇产科学 | 38196篇 |
基础医学 | 267564篇 |
口腔科学 | 37873篇 |
临床医学 | 179105篇 |
内科学 | 333903篇 |
皮肤病学 | 30383篇 |
神经病学 | 131059篇 |
特种医学 | 56283篇 |
外国民族医学 | 366篇 |
外科学 | 219851篇 |
综合类 | 78339篇 |
现状与发展 | 1篇 |
一般理论 | 462篇 |
预防医学 | 150225篇 |
眼科学 | 46272篇 |
药学 | 152676篇 |
9篇 | |
中国医学 | 49807篇 |
肿瘤学 | 87945篇 |
出版年
2019年 | 24712篇 |
2018年 | 29860篇 |
2017年 | 26537篇 |
2016年 | 26059篇 |
2015年 | 27835篇 |
2014年 | 33147篇 |
2013年 | 44210篇 |
2012年 | 56026篇 |
2011年 | 60134篇 |
2010年 | 42876篇 |
2009年 | 47206篇 |
2008年 | 53775篇 |
2007年 | 52822篇 |
2006年 | 52415篇 |
2005年 | 50839篇 |
2004年 | 50857篇 |
2003年 | 48058篇 |
2002年 | 46990篇 |
2001年 | 71056篇 |
2000年 | 68799篇 |
1999年 | 62905篇 |
1998年 | 25963篇 |
1997年 | 24242篇 |
1996年 | 24646篇 |
1995年 | 24262篇 |
1994年 | 23265篇 |
1993年 | 21533篇 |
1992年 | 51631篇 |
1991年 | 50346篇 |
1990年 | 48170篇 |
1989年 | 46004篇 |
1988年 | 42858篇 |
1987年 | 41454篇 |
1986年 | 39571篇 |
1985年 | 37262篇 |
1984年 | 28164篇 |
1983年 | 24676篇 |
1982年 | 17748篇 |
1981年 | 15938篇 |
1980年 | 14919篇 |
1979年 | 26099篇 |
1978年 | 19507篇 |
1977年 | 17072篇 |
1976年 | 16440篇 |
1975年 | 16508篇 |
1974年 | 19125篇 |
1973年 | 18481篇 |
1972年 | 17380篇 |
1971年 | 15850篇 |
1970年 | 14846篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
目的 探讨不同年龄阿尔茨海默病(AD)患者ADC值与年龄的相关性。方法 选取30例AD患者(AD组)和年龄与之相匹配的30名志愿者(对照组),按年龄段各分为6个亚组[55~59岁(n=3)、60~64岁(n=4)、65~70岁(n=9)、71~74岁(n=5)、75~80岁(n=6)、>80岁(n=3)],测量双侧海马、红核、尾状核、杏仁体、壳核ADC值,并进行配对t检验、独立样本t检验、单因素方差分析及Pearson相关分析。结果 AD组红核左、右侧ADC值有统计学差异(P=0.022)。AD组不同年龄亚组右侧海马、双侧尾状核、右侧壳核ADC值差异有统计学意义(P均<0.05);2组不同年龄亚组双侧海马、壳核、尾状核ADC值差异有统计学意义(P均<0.05)。AD组右侧海马(r=0.615,P<0.001)、右侧壳核(r=0.653,P=0.001)及双侧尾状核(左侧:r=0.397,P=0.030;右侧:r=0.429,P=0.020)ADC值与年龄呈正相关。结论 AD患者右侧海马和壳核、双侧尾状核ADC值随年龄增加而增大。ADC值可为临床预测和早期诊断AD脑内右侧海马和壳核、双侧尾状核神经退行性病变提供参考。 相似文献
52.
53.
54.
55.
良性前列腺增生(BPH)是老年男性常见的泌尿系统疾病,其发病与前列腺慢性炎症之间存在显著相关。感染因子、尿液返流、代谢综合征、衰老过程和自身免疫应答在内的几种刺激,通过相应分子途径引起前列腺免疫细胞的组织定位和组成成分发生广泛改变,从而导致免疫系统失调,之后引发的组织损伤和缓慢愈合,导致了BPH发生和进展。本文通过总结良性前列腺增生与前列腺慢性炎症的相关性的临床研究结果,前列腺免疫细胞在病理生理机制层面与前两者之间的内在联系,以及抗炎药物对BPH-LUTS的干预作用,以其为BPH-LUTS的药物研发提供参考。 相似文献
56.
Peter Düking Christoph Zinner Jennifer L. Reed Hans-Christer Holmberg Billy Sperlich 《Scandinavian journal of medicine & science in sports》2020,30(12):2291-2304
Monitoring variations in the functioning of the autonomic nervous system may help personalize training of runners and provide more pronounced physiological adaptations and performance improvements. We systematically reviewed the scientific literature comparing physiological adaptations and/or improvements in performance following training based on responses of the autonomic nervous system (ie, changes in heart rate variability) and predefined training. PubMed, SPORTDiscus, and Web of Science were searched systematically in July 2019. Keywords related to endurance, running, autonomic nervous system, and training. Studies were included if they (a) involved interventions consisting predominantly of running training; (b) lasted at least 3 weeks; (c) reported pre- and post-intervention assessment of running performance and/or physiological parameters; (d) included an experimental group performing training adjusted continuously on the basis of alterations in HRV and a control group; and (e) involved healthy runners. Five studies involving six interventions and 166 participants fulfilled our inclusion criteria. Four HRV-based interventions reduced the amount of moderate- and/or high-intensity training significantly. In five interventions, improvements in performance parameters (3000 m, 5000 m, Loadmax, Tlim) were more pronounced following HRV-based training. Peak oxygen uptake () and submaximal running parameters (eg, LT1, LT2) improved following both HRV-based and predefined training, with no clear difference in the extent of improvement in . Submaximal running parameters tended to improve more following HRV-based training. Research findings to date have been limited and inconsistent. Both HRV-based and predefined training improve running performance and certain submaximal physiological adaptations, with effects of the former training tending to be greater. 相似文献
57.
58.
Vasundhara Sridharan Yuichi Shoda Jaimee L. Heffner Jonathan Bricker 《Substance use & misuse》2019,54(7):1086-1095
Background: Lay belief systems about the malleability of human attributes have been shown to impact behavior change in multiple domains. Addiction mindset—i.e., beliefs about the permanence (vs. malleability) of addiction — may affect cigarette smokers’ ability to quit, but this has never been examined. Objectives: The aims of the present research were to develop a measure of addiction mindset (study 1) and examine its associations with various psychological aspects of quitting smoking (study 2). Methods: In Study 1, using factor analysis of current smokers’ and nonsmokers’ (n?=?600) responses to 22 items designed to measure addiction mindset, we developed a reliable six-item Addiction Mindset Scale (AMS). In Study 2, adult smokers (n?=?200) completed the AMS, and measures of a number of psychological processes related to smoking. Results: Higher scores on the AMS, indicative of the belief that addiction is malleable (referred to as a growth mindset), were positively and significantly associated with greater motivation to quit, greater commitment to quitting, greater self-efficacy to abstain, less attribution of failure to lack of ability to change addiction, and fewer self-reported barriers to cessation (all p’s < .05). Conclusions: The results of this study show a relationship between the beliefs about the permanence of addiction and psychological processes relevant to quitting smoking. The findings underscore the potential of future research exploring how addiction mindsets relate to successful smoking cessation as well as other types of addictive behavior and how they can be applied to change people’s behavior. 相似文献
59.
Stepanova E. S. Makarenkova L. M. Chistyakov V. V. Rybakov Yu. L. Gukasov V. M. Fedotcheva T. A. Parshin V. A. Votyakov V. A. Shimanovskii N. L. 《Pharmaceutical Chemistry Journal》2019,52(12):1016-1020
Pharmaceutical Chemistry Journal - An HPLC-MS method for simultaneous quantitative determination of a novel gestagenic pharmaceutical and two of its metabolites in rat and rabbit blood sera was... 相似文献
60.
M.F. Werner A. López-Rueda F.X. Zarco J. Blasco L. San Román S. Amaro E. Carrero R. Valero L. Oleaga J.M. Macho N. Bargalló 《Radiologia》2019,61(2):143-152